TERRADA-MUSIC-SCORE
Terrada Music Score Co., Ltd. (Shinagawa-ku, Tokyo; CEO: Fujio Noguchi) provided the GVIDO electronic music score device as a supplementary prize for the Piano Talents Competition 2018, an international competition for young pianists held in Milan, Italy from June 5th (Tue.) to June 10th (Sun.), 2018.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180628005438/en/
The Piano Talents Competition 2018, which was held this year for the
eighth time, is an international piano competition that attracts
talented young pianists from around 30 countries worldwide. It was held
at the Casa Verdi
, a location renowned in the classical music
community in Milan. The winners of each of the Kids, Young and Senior
divisions were presented with a GVIDO electronic music score device by
Terrada Music Score in addition to prizes and scholarships. Terrada
Music Score contributes to the support of young pianists that are the
future of the music industry, and expects GVIDO to assist in providing a
comfortable performing environment to musicians.
Please see the
following URL for details on the competition.
http://www.pianofriends.eu/ptcompetition2018.html?lang=en
[Overview of Piano Talents Competition 2018]
Name: Piano
Talents Competition 2018
Host: Pianofriends Association (Founder:
Maestro Vincenzo Balzani; Representative: Professor Catia Iglesias)
Dates:
June 5th (Tue.) – 10th (Sun.), 2018
Venue: Casa Verdi: House of
Rest for Musicians, Buonarroti Square, 29, Milan, Italy
URL: http://www.pianofriends.eu/ptcompetition2018.html?lang=en
Judges:
Hubert Stuppner, Vincenzo Balzani, Raimondo Campisi, Vsevolod Dvorkin,
Philippe Raskin, Catia Iglesias *Titles omitted
Co-sponsors:
Terrada Music Score, Banca Patrimoni Sella & C. and others
[About GVIDO]
The GVIDO dual-screen e-paper music score
device was released in Japan in October 2017, and is available in the
North American and European markets. In addition to functions such as
easy viewing of music scores and being light in weight, its design has
also been well received, and it was awarded the Red Dot Design Award, a
globally renowned German design award, in April 2018.
Site
information: https://en.red-dot.org/
See
the GVIDO site (https://www.gvido.tokyo/
)
for details on GVIDO products.
[GVIDO Store]
URL: https://www.gvidoscore.com/
The
GVIDO store distributing electronic music scores will cooperate with
music score publishers to expand the provision of music scores for
individual pieces of music.
With the addition of AMA Verlag GmbH,
Faber Music Ltd., IEU (Edition – Impronta UG) and SCHOTT MUSIC GmbH &
Co. KG to the currently available Hal Leonard LLC, the global store will
offer pieces published by a total of five companies.
|
[About Terrada Music Score] |
||
| Company Name: | Terrada Music Score Co., Ltd. | |
| Business: | General digital score business | |
| Representative: | Fujio Noguchi, President and CEO | |
| Office: | N Building 5F, 2-2-33 Higashi Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20180628005438/en/
Contact:
[For press inquiries]
Warehouse TERRADA
PR Group
pr@terrada.co.jp
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 03:20:00 CEST | Press release
- To accommodate large-scale TVs and high-end model demands - Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high fun
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 02:27:00 CEST | Press release
Over 250,000 units of Rokid Glasses have already been ordered, integrated with Alipay’s digital payment technology for AR glasses.The integration of payments into AR glasses supports a future of seamless, intuitive commerce—enabling instant, gesture-based transactions, immersive product discovery, and new ways for businesses to engage customers. Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already or
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom